Pharmaceutical company BioNTech said on Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.
Vaccine Maker BioNTech To Use mRNA tech To Target Malaria

12 TEYXH MONO €40
Pharmaceutical company BioNTech said on Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.